The Role of Informed Patient Choice in CRC Screening Adherence

Share on Facebook
Can patient choice play a role in improving colorectal cancer screening rates?

A study recently published in the American Journal of Gastroenterology compared CRC screening adherence in a group patients offering a choice in screening modality to a group offered no choice. Here are four things to know about the study.

•    Of the patients included in the study, 6,397 were offering a choice of a yearly fecal immunochemical test for up to three years vs. one colonoscopy. The other 4,209 patients included in the study were offered FIT or colonoscopy without a choice.
•    The group offered a choice demonstrated FIT adherence of 97.6 percent, 84.1 percent and 72.6 percent in the first three years of follow-up. Patients that chose colonoscopy had an adherence rate of 95.7 percent
•    In group of patients offered no choice, those offered FIT had an adherence rate of 97.5 percent, 78.4 percent and 62.8 percent for the first three years of follow-up. Those offered colonoscopy had an adherence rate of 90.6 percent.
•    Researchers concluded that patients offered a choice of CRC screening modality had a higher adherence rate than patients who were not offered a choice. The results suggest patient choice should be included in CRC screening methods.

More Articles on Gastroenterology:
How Can Gastroenterologists Take Part in Population Health Initiatives?
What Role Can Vitamin D Play in CRC Survival Rate?
8 Things to Know About Gastroenterologist Employment

© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New From Becker's GI & Endoscopy

FDA approves gastroenteropancreatic neuroendocrine tumor drug

Read Now